Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment
- 3 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 33 (6), 1018-1024
- https://doi.org/10.1007/s00134-007-0606-2
Abstract
Objective Using an ex vivo simulation model we set out to estimate the amount of drug lost due to sequestration within the extracorporeal circuit over time. Design Simulated closed-loop extracorporeal membrane oxygenation (ECMO) circuits were prepared using a 1.5-m2 silicone membrane oxygenator. Group A consisted of heparin, dopamine, ampicillin, vancomycin, phenobarbital and fentanyl. Group B consisted of epinephrine, cefazolin, hydrocortisone, fosphenytoin and morphine. Drugs were tested in crystalloid and blood-primed circuits. After administration of a one-time dose of drugs in the priming fluid, baseline drug concentrations were obtained (P0). A simultaneous specimen was stored for stability testing at 24 h (P4). Serial post-membrane drug concentrations were then obtained at 30 min (P1), 3 h (P2) and 24 h (P3) from circuit fluid. Measurements and results One hundred and one samples were analyzed. At the end of 24 h in crystalloid-primed circuits, 71.8% of ampicillin, 96.7% of epinephrine, 17.6% of fosphenytoin, 33.3% of heparin, 17.5% of morphine and 87% of fentanyl was lost. At the end of 24 h in blood-primed extracorporeal circuits, 15.4% of ampicillin, 21% of cefazolin, 71% of voriconazole, 31.4% of fosphenytoin, 53.3% of heparin and 100% of fentanyl was lost. There was a significant decrease in overall drug concentrations from 30 min to 24 h for both crystalloid-primed circuits (p = 0.023) and blood-primed circuits (p = 0.04). Conclusions Our ex vivo study demonstrates serial losses of several drugs commonly used during ECMO therapy. Therapeutic concentrations of fentanyl, voriconazole, antimicrobials and heparin cannot be guaranteed in patients on ECMO.This publication has 34 references indexed in Scilit:
- Extracorporeal Life Support in Pediatric and Neonatal Critical Care: A ReviewJournal of Intensive Care Medicine, 2004
- Pharmacokinetic Changes During Extracorporeal Membrane OxygenationClinical Pharmacokinetics, 2003
- Nosocomial Infections in Adult Patients Undergoing Extracorporeal Membrane OxygenationClinical Infectious Diseases, 1999
- Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenationCritical Care Medicine, 1997
- The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failureCritical Care Medicine, 1996
- Extracorporeal Life Support for Neonatal Respiratory FailureAnnals of Surgery, 1994
- Preliminary Studies of the Effects of Extracorporeal Membrane Oxygenator on the Disposition of Common Pediatric DrugsTherapeutic Drug Monitoring, 1993
- Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheepCritical Care Medicine, 1992
- Tolerance and Dependence in Neonates Sedated with Fentanyl during Extracorporeal Membrane OxygenationAnesthesiology, 1990
- Binding of fentanyl and alfentanil to the extracorporeal circuitActa Anaesthesiologica Scandinavica, 1987